Rate My Professor David Newby

Newby's research focuses on decision making, information needs, pharmacoeconomics, pharmacoepidemiology, pharmacology, and pharmacy practice, utilizing qualitative and quantitative approaches including surveys, interviews, and focus group discussions. He is a Fellow of the Pharmaceutical Society of Australia since 2018 and has received the Outstanding Contribution to Student Learning award from the Australian Learning & Teaching Council in 2009 and the Vice-Chancellor's Award for Outstanding Contribution to Student Learning from the University of Newcastle in 2007. Additionally, he holds a ministerial appointment to the Pharmaceutical Benefits Advisory Committee. His key publications include co-authoring Community Pharmacy: Symptoms, Diagnosis and Treatment (2008, 2011, 2012, 2015 editions with P. Rutter) and Pharmacology for Pharmacy and the Health Sciences (2010, 2016, 2017 with M. Boarder and others). He has contributed book chapters on topics such as women's health, paediatrics, gastroenterology, and evidence-based pharmacy practice, along with conference papers on interprofessional learning, pharmacogenomics of antidepressants, and diabetes risk assessment in community pharmacy.